Lupin gets USFDA nod for generic medication

Indian drug maker Lupin has received tentative approval from the US Food and Drug Administration (FDA) to market a generic medication used to reduce excessive daytime sleepiness. Lupin plans to produce the medication at its facility in Somerset, US.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/mWAoyeZ
via IFTTT